Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Tobacco Smoke Activates Human Papillomavirus 16 p97 Promoter and Cooperates with High-Risk E6/E7 for Oxidative DNA Damage in Lung Cells.

Peña N, Carrillo D, Muñoz JP, Chnaiderman J, Urzúa U, León O, Tornesello ML, Corvalán AH, Soto-Rifo R, Aguayo F.

PLoS One. 2015 Apr 1;10(4):e0123029. doi: 10.1371/journal.pone.0123029. eCollection 2015.

2.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015.

3.

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens.

Buonaguro FM, Tornesello ML, Buonaguro L.

J Transl Med. 2015 Jan 27;13(1):33. doi: 10.1186/s12967-015-0400-9.

4.

Antigen-specific vaccines for cancer treatment.

Tagliamonte M, Petrizzo A, Tornesello ML, Buonaguro FM, Buonaguro L.

Hum Vaccin Immunother. 2014;10(11):3332-46. doi: 10.4161/21645515.2014.973317.

PMID:
25483639
5.

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.

Tornesello ML, Annunziata C, Buonaguro L, Losito S, Greggi S, Buonaguro FM.

J Transl Med. 2014 Sep 16;12:255. doi: 10.1186/s12967-014-0255-5.

6.

HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.

Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F.

Cancer Lett. 2014 Sep 1;351(2):198-205. doi: 10.1016/j.canlet.2014.06.003. Epub 2014 Jun 24. Review.

PMID:
24971935
7.

Cancer diagnostic and predictive biomarkers.

Buonaguro FM, Pauza D, Tornesello ML, Hainaut P, Franco R, Marincola FM.

Biomed Res Int. 2014;2014:980163. doi: 10.1155/2014/980163. Epub 2014 Apr 3. No abstract available.

8.

Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines.

Shoja Z, Tagliamonte M, Jalilvand S, Mollaei-Kandelous Y, De Stradis A, Tornesello ML, Buonaguro FM, Buonaguro L.

J Med Virol. 2015 Jan;87(1):102-11. doi: 10.1002/jmv.23973. Epub 2014 May 5.

PMID:
24797918
9.

Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.

Tornesello ML, Giorgi Rossi P, Buonaguro L, Buonaguro FM; HPV Prevalence Italian Working Group.

Front Oncol. 2014 Feb 20;4:31. doi: 10.3389/fonc.2014.00031. eCollection 2014.

10.

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach.

Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L.

J Transl Med. 2014 Jan 15;12:11. doi: 10.1186/1479-5876-12-11.

11.

Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.

Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM.

Biomed Res Int. 2013;2013:519619. doi: 10.1155/2013/519619. Epub 2013 Dec 9. Review.

12.

Oncolytic virus therapies.

Buonaguro FM, Tornesello ML, Izzo F, Buonaguro L.

Pharm Pat Anal. 2012 Nov;1(5):621-7. doi: 10.4155/ppa.12.65. Review.

PMID:
24236929
13.

VLPs and particle strategies for cancer vaccines.

Ungaro F, Conte C, Quaglia F, Tornesello ML, Buonaguro FM, Buonaguro L.

Expert Rev Vaccines. 2013 Oct;12(10):1173-93. doi: 10.1586/14760584.2013.836909. Review.

PMID:
24124878
14.

Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.

Di Monta G, Caracò C, Benedetto L, La Padula S, Marone U, Tornesello ML, Buonaguro FM, Simeone E, Ascierto PA, Mozzillo N.

Eur J Surg Oncol. 2014 Jan;40(1):61-6. doi: 10.1016/j.ejso.2013.09.002. Epub 2013 Sep 12.

PMID:
24075826
15.

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate.

Visciano ML, Tagliamonte M, Stewart-Jones G, Heyndrickx L, Vanham G, Jansson M, Fomsgaard A, Grevstad B, Ramaswamy M, Buonaguro FM, Tornesello ML, Biswas P, Scarlatti G, Buonaguro L; NGIN Consortium.

J Transl Med. 2013 Jul 8;11:165. doi: 10.1186/1479-5876-11-165.

16.

Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies.

Ruocco E, Ruocco V, Tornesello ML, Gambardella A, Wolf R, Buonaguro FM.

Clin Dermatol. 2013 Jul-Aug;31(4):413-22. doi: 10.1016/j.clindermatol.2013.01.008. Review.

PMID:
23806158
17.

Challenges in cancer vaccine development for hepatocellular carcinoma.

Buonaguro L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM.

J Hepatol. 2013 Oct;59(4):897-903. doi: 10.1016/j.jhep.2013.05.031. Epub 2013 May 25. Review. Erratum in: J Hepatol. 2014 Jan;60(1):237.

18.

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.

Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM.

Genomics. 2013 Aug;102(2):74-83. doi: 10.1016/j.ygeno.2013.04.001. Epub 2013 Apr 11. Review.

19.

Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.

De Giorgi V, Buonaguro L, Worschech A, Tornesello ML, Izzo F, Marincola FM, Wang E, Buonaguro FM.

PLoS One. 2013;8(2):e56153. doi: 10.1371/journal.pone.0056153. Epub 2013 Feb 18.

20.

Developments in virus-like particle-based vaccines for HIV.

Buonaguro L, Tagliamonte M, Visciano ML, Tornesello ML, Buonaguro FM.

Expert Rev Vaccines. 2013 Feb;12(2):119-27. doi: 10.1586/erv.12.152. Review.

PMID:
23414404
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk